Loft M, Lok SW, De Boer R, Malik L, et al. Addition of endocrine therapy to dual anti-HER2 targeted therapy in initial treatment of HER2 + /HR + metastatic breast cancer. Breast Cancer Res Treat 2023 Jan 9. doi: 10.1007/s10549-022-06856.
PMID: 36624321